Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization (Q34495535)

2 August 2017

title

Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization (English)

1 reference

2 August 2017

1 reference

Gaetano Rocco

11

0 references

Maria Vincenza Carriero

Maria Vincenza Carriero

12

0 references

Antonello La Rocca

9

Antonello La Rocca

1 reference

2 August 2017

1

Katia Bifulco

1 reference

Immacolata Longanesi-Cattani

2 August 2017

2

Immacolata Longanesi-Cattani

1 reference

2 August 2017

Annarosaria De Chiara

4

Annarosaria De Chiara

1 reference

2 August 2017

5

Flavio Fazioli

1 reference

2 August 2017

10

Gaetano Apice

1 reference

2 August 2017

Maria Teresa Masucci

3

1 reference

2 August 2017

Gioconda Di Carluccio

6

1 reference

2 August 2017

Giuseppe Pirozzi

7

1 reference

2 August 2017

Michele Gallo

8

1 reference

2 August 2017

publication date

30 December 2010

1 reference

2 August 2017

1 reference

2 August 2017

volume

2011

1 reference

2 August 2017

page(s)

842842

1 reference

Creative Commons Attribution 3.0 Unported

2 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Regulation of cell signalling by uPAR.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

The clinical approach towards chondrosarcoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

The urokinase plasminogen activator receptor as a gene therapy target for cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Structural basis of interaction between urokinase-type plasminogen activator and its receptor

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

uPA and uPAR in fibrinolysis, immunity and pathology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

A rapid in vitro assay for quantitating the invasive potential of tumor cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F842842

Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F842842

Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2011%2F842842

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3021884

uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view

27 October 2018

1 reference

12 December 2020

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization

1 reference

12 December 2020

Cell invasiveness in sarcomas: a possibly useful clinical correlation

1 reference

12 December 2020

In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer

1 reference

12 December 2020

Plasminogen activation and cancer

1 reference

12 December 2020

Microvasculature and VEGF expression in cartilaginous tumors

1 reference

12 December 2020

The soluble form of urokinase receptor promotes angiogenesis through its Ser⁸⁸-Arg-Ser-Arg-Tyr⁹² chemotactic sequence

1 reference

12 December 2020

Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo

1 reference

12 December 2020

Risk factors for survival and local control in chondrosarcoma of bone

1 reference

12 December 2020

Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/842842

1 reference

2 August 2017

1 reference

2 August 2017

1 reference